Clinical Trial Update: Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating pembrolizumab in combination with carboplatin, paclitaxel, and radiation for early-stage anal ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Dustin Deming | Conditions: Anal Cancer | Phase 2 | Status: RECRUITING